The Relationship of Risperidone Therapy Pattern to The Symptoms That Appear in Schizophrenia Patients Under Out Patient Treatment
DOI:
https://doi.org/10.59188/eduvest.v5i2.33264Keywords:
schizophrenia, Risperidone, Monotherapy, Combination Therapy, SymptomsAbstract
Schizophrenia has a high psychosocial burden and environmental influences cause an increase in patient mortality. Management of schizophrenia can be done using two methods, namely pharmacological therapy and non-pharmacological therapy. Positive symptoms can be controlled with pharmacological therapy using antipsychotic medication. After treatment of positive symptoms, negative symptoms are likely to persist. Antipsychotics are the primary therapy for schizophrenia sufferers. Risperidone is known to be the first line for schizophrenia sufferers because of the mild reactions it causes.The therapy received by schizophrenia patients, either monotherapy or in combination, has an effect on the symptoms that appear in the patient. This study aims to evaluate the pattern of antipsychotic therapy given in relation to the symptoms that appear after being given therapy. It is known that at the Jombang Regional Hospital Mental Health Polytechnic there are patients with various mental disorders and most of them are schizophrenic sufferers with a low level of public awareness so they do not know the symptoms they are experiencing. The inclusion criteria in this study were patients diagnosed with schizophrenia who received the antipsychotic risperidone alone or in combination with other antipsychotics in the period January-December 2021. Data analysis used the Chi-square test to see the relationship between the administration of risperidone therapy patterns and the symptoms that appeared in patients. After the analysis was carried out, the results showed that the risperidone therapy pattern had no relationship with the symptoms that appeared after therapy. This can be caused by several factors including individual factors.
References
Afitriyani, Novi, Dwinta, Eliza, Putri, Imram Radne Rimba, & Astuti, Witri Susila. (2024). Cost Effectiveness Analysis Of The Use Of Atypical Monotherapy Antipsychotics With Atypical And Typical Combinations In Schizophrenia Inpatient Patients At The Grhasia Yogyakarta Mental Hospital. Ibnu Sina Scientific Journal (Jiis): Pharmaceutical And Health Sciences, 8(3), 46–56. Https://Doi.Org/10.36387/Jiis.V8i3.1656
Anas, Dwi Yulinar Buhar, Arman, & Gobel, Fatmah Afrianty. (2022). Risk Factors for the Incident of Schizophrenia in the Working Area of the West Malangke Health Center, Kec. West Malangke District. North Luwu in 2022. Journal of Muslim Community Health, 4(3), 200–210.
Archibald, Luke, Brunette, Mary F., Wallin, Diana J., & Green, Alan I. (2019). Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder. Alcohol Research : Current Reviews, 40(1). https://doi.org/10.35946/arcr.v40.1.06
Aryani, F., & Sari, Oelan. (2016). Description of Antipsychotic Use Patterns in Schizophrenia Patients in Mental Hospital Inpatient Rooms. Journal of Pharmaceutical Management and Services, 6(1), 35–40.
Assion, H. J., Schweppe, A., Reinbold, H., & Frommberger, U. (2019). Pharmacological treatment for schizoaffective disorder : A comparison with schizophrenia and bipolar disorder. Der Nervenarzt, 90(Suppl 1), 1–8. https://doi.org/10.1007/s00115-018-0507-3
Astuti, Ana Puji, Tri, Susilo, & Putra, Sang Made Adiatma. (2017). The relationship between medication adherence and the period of relapse in schizophrenia patients: hallucinations in a mental hospital. Prof. Dr. Soeroyo Magelang. Cendikia Utama Nursing and Public Health Journal, 6(2), 53–86.
Belbase, Mohan, & Adhikari, Jyoti. (2020). Socio Demographic Profile and Risperidone Response in New Versus Old Schizophrenia Patients. Journal of Nepalgunj Medical College, 18(1), 82–85. https://doi.org/10.3126/jngmc.v18i1.35208
Boczek, Tomasz, Mackiewicz, Joanna, Sobolczyk, Marta, Wawrzyniak, Julia, Lisek, Malwina, Ferenc, Bozena, Guo, Feng, & Zylinska, Ludmila. (2021). The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines. Cells, Vol. 10. https://doi.org/10.3390/cells10051228
Citrome, Lesliea; Shope, Constance B; Nolan, Karen A.; Czobor, Nutmeg; Volavka, Jan. (2007). Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility. International Clinical Psychopharmacology, 22(6), 352–362. https://doi.org/10.1097/YIC.0b013e3281c61baf
Febriana, Betie, Susanto, Wigyo, Rochmawati, Dwi Heppy, & Setiawati, Wahyu Endang. (2020). Family Support is the Key to Compliance with the Treatment of Relapsing Schizophrenia Patients. Nursing Journal, 15(1 Special Issue), 457–461. https://doi.org/10.20473/jn.v15i1Sp.20361
Feng, Ziqiao, Zhang, Yunqiao, You, Xu, Zhang, Wenyu, Ma, Yuhan, Long, Qing, Liu, Zijun, Hao, Wei, Zeng, Yong, & Teng, Zhaowei. (2020). Effects of risperidone on blood levels of interleukin-6 in schizophrenia: A meta-analysis. Medicine, 99(15), e19694. https://doi.org/10.1097/MD.0000000000019694
Harvey, Philip D., Nakamura, Hiroshi, & Miura, Sadanori. (2020). Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study. Neuropsychopharmacology Reports, 40(1), 63–72. https://doi.org/10.1002/npr2.12089
Hemalatha, B., Ramnath, E., & Tamiljothi, E. (2022). A comparison of efficacy, mechanisms, and side effects of clozapine and risperidone in patients with schizophrenia. World Journal of Biological Pharmacy and Health Sciences, 12(1), 066–080. https://doi.org/10.30574/wjbphs.2022.12.1.0151
Ih, Hariyanto, Putri, Rizka A., & Untari, Eka K. (2016). Different Types of Antipsychotic Therapies on Length of Stay of Acute Schizophrenia Patients in Sungai Bangkong Regional Mental Hospital Pontianak. Indonesian Journal of Clinical Pharmacy, 5(2), 115–122. https://doi.org/10.15416/ijcp.2016.5.2.115
Indriani, Anggie, Ardiningrum, Wikan, & Febrianti, Yosi. (2020). Study on the Use of Combination Antipsychotics in Schizophrenia Patients at Yogyakarta Hospital. Pharmaceutics Magazine., 4(Suppl 1), 201–211. https://doi.org/10.24198/mfarmasetika.v4i0.25882
Jarut, Yulia Maria, Fatimawali, & Wiyono, Weny I. (2013). Review of the Use of Antipsychotics in the Treatment of Schizophrenia in Hospitals Prof. Dr. V. L. Ratumbuysang Manado Period January 2013- March 2013. Pharmaceutical Scientific Journal, 2(03), 54–57.
Indonesian Ministry of Health. (2015). NATIONAL GUIDELINES FOR MENTAL MEDICAL SERVICES. Minister of Health Decree No. 71 of 2015, (1), 1–27.
Kurniasari, Cecilia Indri, & Dwidiyanti. (2019). Nursing Therapy in Overcoming Social Interaction Problems in Schizophrenia Patients: Literature Review. Journal of Psychiatric Nursing, 2(1), 41–46.
Lisni, Ida, Patti, Dharma, & Saidah, Siti. (2017). Analysis Of Potential Drug Interactions In The Management Of Adult Schizophrenia Patients In The Inpatition Installation Of The Mental Hospital Of West Java Province. Galenika Pharmacy Journal, (Vol 4 No. 3 (2017): Galenika Pharmacy Journal Volume 4 No. 3, 2017), 72–83.
Mahari, Reny Puspita, Susanti, Ressi, & Robiyanto, Rubiyanto. (2019). Profile Of Anticholinergic Burden In The Psychogeriatrics Of Schizophrenia Patients At The Sungai Bangkong Pontianak Mental Hospital. Journal Of Pharmacy Students, Faculty Of Medicine, Untan, 4(1), 1–9. Https://Doi.Org/10.21608/Pshj.2022.250026
Papiilya, Jeanete Ophilia. (2019). Case Report Psychological Dynamics Of Residual Schizophrenia Patients: Case Report Jeanete Ophilia Papilaya FKIP Pattimura University Corresponding author e-mail : jeaneteophilia@gmail.com . Molucca Medica, 12, 25–33.
Puspitasari, Candra, Dewi, Ni Made Amelia, Aini, Siti, Pratama, Iman, & Hasina, Raisya. (2022). Antipsychotic prescribing patterns for Schizophrenia Patients at RSJ Mutiara Sukma NTB Province In 2020. Journal of Science and Health, 4, 308. https://doi.org/10.25026/jsk.v4i3.1151
Saputri, Rika Paramitha, Sulistyawati, Elina Endang, & Untari, Meta Kartika. (2019). Analysis of the Rationality of Antipsychotic Use in Schizophrenia Patients in the Inpatient Installation of RSJD Atma Husada Mahakam Samarinda in 2016. Pharmacon: Indonesian Pharmacy Journal, 15(1), 19–28. https://doi.org/10.23917/pharmacon.v15i1.6180
Sari, Rani Sopiya, Suyanti, Titi Sri, & B, Slamet Wijawa. (2023). Mental Nursing Care for Mrs. M With Sensory Perception Disorder: Auditory Hallucinations Due to Schizophrenia Schizoaffective Disorder in Madrim Room RSJD dr. Amino Gondohutomo, Central Java Province. Journal of Health and Nursing Sciences, 1(4), 83–93.
Schneider, F., & Kircher, T. (2020, January). [Schizophrenia]. Der Nervenarzt, Vol. 91, p. 1. https://doi.org/10.1007/s00115-019-00856-1
Soria-Chacartegui, Paula, Villapalos-García, Gonzalo, Zubiaur, Pablo, Abad-Santos, Francisco, & Koller, Dora. (2021). Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in Pharmacology, 12(July), 1–16. https://doi.org/10.3389/fphar.2021.711940
Tarigas, Jesica, Untari, Eka Kartika, & Nurmainah, Nurmainah. (2018). Analysis of the Potential for Serotonin Syndrome in the Use of. Pharmacy Students, Faculty of Medicine, Tajungpura University, (December), 1–8.
Utami, Virnia Wanda, Darajati, Mudrikah, & Puspitasari, Candra Eka. (2022). Potential drug interactions in schizophrenia patients at Mutiara Sukma Mental Hospital in 2020. Sasambo Journal of Pharmacy, 3(1), 36–42. https://doi.org/10.29303/sjp.v3i1.151
Yuniartika, Wachidah, Santi, Catur Novita, & Azizah S, Nur. (2019). Reducing Anxiety in Schizophrenia Patients in Mental Hospitals Using Music Therapy. UNSIQ Journal of Research and Community Service, 6(1), 26–30. https://doi.org/10.32699/ppkm.v6i1.496
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aghnia Fuadatul Inayah, Putri Ardana Wahyu Andika, Alvina Arum Puspitasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
